Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the merits of prioritising clinically extremely vulnerable children for a covid-19 vaccine if licensed for use in children.
The Pfizer/BioNTech vaccine has now been authorised by the Medicines and Healthcare products Regulatory Agency for use in children aged 12 to 15 years old in the United Kingdom. The Government will now be guided by the advice of experts, including the Joint Committee on Vaccination and Immunisation (JCVI), on any potential routine deployment of COVID-19 vaccination in children.